Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease

Author(s):
Boer, H.C. de; Solingen, C. van; Prins, J.; Duijs, J.M.G.J.; Huisman, M.V. (0000-0003-1423-5348); Rabelink, T.J.; Zonneveld, A.J. van
Published
2013
Publication type
Article / Letter to editor
miR-126plateletsaspirindiabetes mellitus type 2
Date issued
2013-11-30
Language
English
Is part of
European Heart Journal (2013), Vol. 34, no. 44, p. 3451-3457
hdl
1887/111292
doi
10.1093/eurheartj/eht007